VARIOUS TREATMENT PATTERN & MEDICAL PROCEDURES TO TREAT AND PREVENT MONKEY POX IN HUMAN
SHREYA SINGH
, MEGHNA MISRA , PREETI , SHIPRA SINGH , KRISHNA JEE
Cytomegalovirus (CMV), Cidofovir, Kinase Thymidylate, Smallpox Vaccine, Monkey Pox
The United Nation Agency or WHO has promulgated the recent multiregional Monkey-Pox outbreak a global major health threat. The zoonotic virus that causes monkeypox is found in West and Central Africa. It is a member of the family Poxviridae, which is often made up of large, complicated, linear, enclosed viruses with double strands of DNA. Monkey pox frequently manifests as fever, myalgia, tiredness, lymphadenopathy, and a strong headache. The skin lesions usually appear one to three days after the fever starts. In intimate touch with an infected individual or animal, monkeypox is spread.There isn't a specific drug for monkey pox at the moment; instead, antiviral medications that have been approved for smallpox infections, such as tecovirimat, cidofovir, and brincidofovir, are the only accessible treatments. Vaccinia Immune The U.S. Food and Drug Administration has authorized intravenous globulin for treating issues related to vaccinations.. DNA Ligase is used to diagnose it. The U.S. Food and Drug Administration presently have licenses for two vaccinations. The WHO advises against using first-generation smallpox vaccines that are kept in national stocks in certain nations because they do not adhere to the most recent safety and production requirements. In 1970, the first reports of human monkey pox were made. Numerous epidemics have since been brought on by it, mostly in central and west Africa. IN In this review we will discuss about an updated summary of our current understanding of the pathophysiology, symptoms, treatment patterns, prevention, transmission, and circulation of monkey pox in human communities. Finally, conclusions and future prospects are reviewed.
"VARIOUS TREATMENT PATTERN & MEDICAL PROCEDURES TO TREAT AND PREVENT MONKEY POX IN HUMAN", IJSDR - International Journal of Scientific Development and Research (www.IJSDR.org), ISSN:2455-2631, Vol.10, Issue 3, page no.b510-b525, March-2025, Available :https://ijsdr.org/papers/IJSDR2503163.pdf
Volume 10
Issue 3,
March-2025
Pages : b510-b525
Paper Reg. ID: IJSDR_301115
Published Paper Id: IJSDR2503163
Downloads: 000128
Research Area: Pharmacy All
Country: ROORKEE / HARIDWAR, UTTARAKHAND, India
ISSN: 2455-2631 | IMPACT FACTOR: 9.15 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 9.15 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJSDR(IJ Publication) Janvi Wave
